Increasing venture capital investment in spinal surgery: an analysis of investments from 2000 to 2023.

IF 4.9 1区医学 Q1 CLINICAL NEUROLOGY Spine Journal Pub Date : 2024-09-26 DOI:10.1016/j.spinee.2024.09.014

Ravi Dhawan, Alex B Boyle, Akshay Nair, Denys Shay

{"title":"Increasing venture capital investment in spinal surgery: an analysis of investments from 2000 to 2023.","authors":"Ravi Dhawan, Alex B Boyle, Akshay Nair, Denys Shay","doi":"10.1016/j.spinee.2024.09.014","DOIUrl":null,"url":null,"abstract":"Background context: Venture capital (VC) plays a vital role in advancing spinal surgery technologies, driven by the growing burden of spinal disorders and high healthcare costs. Despite increasing interest, trends in VC funding for spinal surgery remain understudied.Purpose: This study aimed to examine temporal and thematic trends in VC investments in spinal surgery companies from 2000 to 2023.Study design/setting: A retrospective cross-sectional study analyzing VC investment trends in privately held US-based spinal surgery companies.Methods: Using the PitchBook database, we analyzed 1001 VC investments in 227 spinal surgery companies between 2000 and 2023. Investments were categorized into surgical devices, noninvasive devices, biotechnology, surgical software, and clinical services. Total and annual investments were quantified in USD.Results: From 2000 to 2023, $5.37 billion was invested in spine surgery, with nonsurgical devices receiving the largest share (42.6%), followed by surgical devices (26.3%) and biotechnology (22.2%). Annual investment increased by 1782%, with a decline in 2023 likely due to macroeconomic factors.Conclusions: VC funding in spinal surgery has grown significantly, especially in noninvasive technologies. Further research is needed to assess the long-term impact of these investments and explore alternative financing models.","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":null,"pages":null},"PeriodicalIF":4.9000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spine Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.spinee.2024.09.014","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background context: Venture capital (VC) plays a vital role in advancing spinal surgery technologies, driven by the growing burden of spinal disorders and high healthcare costs. Despite increasing interest, trends in VC funding for spinal surgery remain understudied.

Purpose: This study aimed to examine temporal and thematic trends in VC investments in spinal surgery companies from 2000 to 2023.

Study design/setting: A retrospective cross-sectional study analyzing VC investment trends in privately held US-based spinal surgery companies.

Methods: Using the PitchBook database, we analyzed 1001 VC investments in 227 spinal surgery companies between 2000 and 2023. Investments were categorized into surgical devices, noninvasive devices, biotechnology, surgical software, and clinical services. Total and annual investments were quantified in USD.

Results: From 2000 to 2023, $5.37 billion was invested in spine surgery, with nonsurgical devices receiving the largest share (42.6%), followed by surgical devices (26.3%) and biotechnology (22.2%). Annual investment increased by 1782%, with a decline in 2023 likely due to macroeconomic factors.

Conclusions: VC funding in spinal surgery has grown significantly, especially in noninvasive technologies. Further research is needed to assess the long-term impact of these investments and explore alternative financing models.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

增加脊柱外科风险投资：对 2000 年至 2023 年投资的分析。

背景情况：风险投资（VC）在推动脊柱外科技术发展方面发挥着至关重要的作用，而脊柱疾病和高昂的医疗费用则是推动这一发展的主要因素。目的：本研究旨在探讨 2000 年至 2023 年风险投资在脊柱外科公司投资的时间和主题趋势：一项回顾性横断面研究，分析美国私人控股脊柱外科公司的风险投资趋势：利用PitchBook数据库，我们分析了2000年至2023年期间对227家脊柱外科公司的1001笔风险投资。投资分为手术器械、无创器械、生物技术、手术软件和临床服务。投资总额和年投资额以美元为单位：从 2000 年到 2023 年，脊柱外科的投资额为 53.7 亿美元，其中非手术设备所占份额最大（42.6%），其次是手术设备（26.3%）和生物技术（22.2%）。年投资额增长了1782%，2023年可能因宏观经济因素而有所下降：脊柱外科领域的风险投资大幅增长，尤其是在无创技术方面。需要进一步研究以评估这些投资的长期影响，并探索其他融资模式。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Spine Journal 医学-临床神经学

CiteScore

8.20

自引率

6.70%

发文量

680

审稿时长

13.1 weeks

期刊介绍： The Spine Journal, the official journal of the North American Spine Society, is an international and multidisciplinary journal that publishes original, peer-reviewed articles on research and treatment related to the spine and spine care, including basic science and clinical investigations. It is a condition of publication that manuscripts submitted to The Spine Journal have not been published, and will not be simultaneously submitted or published elsewhere. The Spine Journal also publishes major reviews of specific topics by acknowledged authorities, technical notes, teaching editorials, and other special features, Letters to the Editor-in-Chief are encouraged.